| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6002030 | Thrombosis Research | 2014 | 4 Pages |
Abstract
Anti-angiogenic treatment with 2ME supressed the HIF1-mediated angiogenic drive in local vein wall and attenuated venous thrombus resolution. The potential pro-thrombotic effect of anti-angiogenic agents should be carefully considered when managing venous thromboembolic events in cancer patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Colin E. Evans, Steven P. Grover, Prakash Saha, Julia Humphries, Jung-whan Kim, Bijan Modarai, Alberto Smith,